: Exclusive: Three possible outcomes for stalled tech-funding bill, according to its co-author
Rep. Ro Khanna talks about what’s at risk as Congressional stalemate continues.
Read MoreRep. Ro Khanna talks about what’s at risk as Congressional stalemate continues.
Read MoreHi, MarketWatchers. Don’t miss these top stories. The solution to the labor shortage in construction?…
Read MoreThe Federal Reserve’s inspector general said there was no evidence to substantiate allegations that Fed…
Read MoreThe pandemic unleashed a “she-cession” where the financial fallout from lockdowns, remote schooling and fewer…
Read MoreInflation has been the big economic story of 2022. Steep increases in consumer prices have…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreTwitter Inc. has a new bullish backer on Wall Street, as Rosenblatt Securities said the…
Read MoreIn 2021, more than 40% of Americans lived in a county that was hit by…
Read More
Manchin could limit Democrats’ budget bill to just drug-pricing reforms, analyst says
Key Democratic Sen. Joe Manchin is expressing alarm again about high prices, saying Congress shouldn’t…
Read More